New strengths of Targinact

Napp has launched two new strengths of Targinact (oxycodone/naloxone). The 5mg/2.5mg and 40mg/20mg tablets provide greater dosing flexibility.

The starting dose remains 10mg/5mg, but the new lower-strength tablet allows a more gradual and individually tailored approach to dose titration. The new higher-strength preparation reduces tablet burden for patients requiring the maximum dose.

Furthermore, Targinact is now licensed for use at doses up to a maximum of 80mg oxycodone hydrochloride/40mg naloxone hydrochloride daily.

View Targinact drug record

Further information: Napp

Want news like this straight to your inbox?
Sign up for our bulletins

Have you registered with us yet?

Register now to enjoy more articles and free email bulletins

Already registered?
Sign in

Register or Subscribe to MIMS

GPs can get MIMS print & online and GPonline for free when they register online – take 2 minutes, and make sure you get your free MIMS access! If you're not a GP, you can subscribe to MIMS for full access.

Register or subscribe

MIMS Dermatology

Read the latest issue online exclusively on MIMS Learning.

Read MIMS Dermatology

MIMS Adviser

Especially created for prescribing influencers.

Request free copy

Mobile apps

MIMS: access the full drug database and quick-reference tables on the go

MIMS Diagnosis and Management: concise information on signs and symptoms, investigations and diseases